Financials

Discussions Technicals Seasonals

NXGN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NEXTGEN BIOMED LTD operating, investing, and financing activities

NXGN free cash flow for H2 24 is -1.16 M ILS. For 2024, NXGN free cash flow was -2.16 M ILS and operating cash flow was -2.06 M ILS.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: ILS

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—